Scientific publications

Advancing knowledge through peer-reviewed research and academic contributions

Explore our contributions to the scientific community. This page lists peer-reviewed articles, research papers and academic publications authored or co-authored by TauRx scientists.

Filter by date:

Sort by:

Wischik, C.M., et al (2022)

Oral Tau Aggregation Inhibitor for Alzheimer’s Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate

Download the publication

Read at The Journal of Prevention of Alzheimer's Disease

Kondak, C., et al, (2022)

Hydromethylthionine enhancement of central cholinergic signalling is blocked by rivastigmine and memantine

Download the publication

Read at Journal of Neurochemistry

Riedel, G, et al. (2020)

Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model

Download the publication

Read at National Library of Medicine

Schelter, B.O., et al. (2019)

Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer’s Disease

Download the publication

Read at Journal of Alzheimer's Disease

Further reading

Portrait of smiling afro senior man looking at camera on the street

Education, advocacy and resources

Read about our enduring focus on education, our ongoing work with GT Diagnostic Centre, and the important role played by patient advocacy groups across the world.

Circular Ribbons with QUESTION MARK Symbols - Blue Gradient Background - 3D Rendering

Frequently Asked Questions (FAQs)

Find out more about TauRx, Alzheimer's and how our work could impact those living with the disease

Young boys reading newspaper with their senior adult grandfather in the living room

Keeping you informed of our latest breakthroughs and company developments